Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres

ConclusionsCefepime/zidebactam demonstrated excellent activity against Enterobacteriaceae andP. aeruginosa, although activity was reduced in carbapenem-non-susceptible isolates. The activity againstA. baumannii was reduced and studies examining the therapeutic efficacy in strains with high cefepime/zidebactam MICs are warranted.

https://academic.oup.com/jac/article/74/10/2938/5572015?rss=1

Source: Journal of Antimicrobial Chemotherapy - July 11, 2019 Category: Microbiology Source Type: research